EUCTR2013-003080-59-IT进行中（未招募）不适用
PHASE III ITALIAN MULTICENTER STUDY COMPARING THE COMBINATION OF 5-FLUOROURACIL/FOLINIC ACID, OXALIPLATIN AND IRINOTECAN (FOLFOXIRI) VERSUS GEMCITABINE AS ADJUVANT TREATMENT FOR RESECTED PANCREATIC CANCER
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 310
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-histological diagnosis of pancreatic cancer
- •-surgical resection with curative intent within 10 weeks before of enrollment (stage I-III)
- •-absence of evidence of metastases (cM0)
- •-age 18-75
- •-ECOG performance status 0-1
- •-adequate bone marrow, liver and renal function
- •-written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 210
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 100
排除标准
- •-evidence of metastases
- •-CA19.9 higher than 2.5 x ULN (upper limit of normal range)
- •-precedent chemotherapy or radiotherapy
- •-coexisting malignancies
- •-relevant coexisting diseases that could contraindicate the participation to the study
- •-hypersensitivity/intolerance to the drugs in study
- •-pregnancy or breastfeeding
- •-neurotoxicity of grade > 1
- •-malabsorption syndrome
研究者
相似试验
进行中（未招募）
不适用
A PHASE III MULTICENTER, RANDOMIZED STUDY COMPARING CONSOLIDATION WITH (90)YTTRIUM-LABELED IBRITUMOMAB TIUXETAN (ZEVALIN®) RADIOIMMUNOTHERAPY VS AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA (FL) AGED 18-65 YEARSEUCTR2012-000251-14-ITFONDAZIONE ITALIANA LINFOMI ONLUS
进行中（未招募）
1 期
A MULTICENTER RANDOMIZED PHASE III STUDY COMPARING FIXED DOSES WITH TOXICITY-ADJUSTED DOSES OF STANDARD CHEMOTHERAPY WITH CISPLATIN AND ETOPOSIDE IN PATIENTS AFFECTED BY ADVANCED SMALL CELL LUNG CANCER - STAD-1MedDRA version: 9.1Level: LLTClassification code 10059514Term: Small cell lung cancer metastaticSmall cell lung cancerEUCTR2006-003995-36-ITISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - FONDAZIONE G. PASCALE160
进行中（未招募）
不适用
MULTICENTRIC RANDOMIZED PHASE III STUDY COMPARING GEFITINIB VERSUS PLATINUM-BASED CHEMOTHERAPY IN EGFR FISH POSITIVE NSCLC PATIENTS (RANGE) - RANGEPatients with locally advanced or metastatic NSCLC, EGFR FISH positive, candidate for a first-line platinum-based chemotherapy will be considered eligible for the trial.MedDRA version: 9.1Level: LLTClassification code 10025065Term: Lung carcinoma cell type unspecified recurrentEUCTR2008-002018-23-ITFONDAZIONE HUMANITAS PER LA RICERCA
进行中（未招募）
不适用
A multicenter phase III, randomized comparison of the safety and efficacy of weekly Tocosol paclitaxel vs. weekly paclitaxel injection in the treatment of metastatic breast cancerMedDRA version: 6.1Level: HLGTClassification code 10006291Metastatic Breast CancerEUCTR2005-002428-33-ITSONUS PHARMACEUTICALS, INC.900
进行中（未招募）
1 期
n estudio multicéntrico de fase III realizado con un grupo paralelo aleatorizado y enmascaramiento para los evaluadores para comparar la eficacia y seguridad de dos formulaciones r-hFSH (AFOLIA frente a Gonal-f®) en mujeres para el tratamiento de reproducción asistida. A phase III assessor-blinded randomised parallel group multi-centre study to compare efficacy adn safety of two r-hFSH formulations (AFOLIA and Gonal-f®) in women for assisted reproductive treatment - not availableEstimulación del desarrollo de multiples folículos en pacientes femeninas que estan en tratamiento de reproducción asistida. Stimulation of multifollicular develoment in patients undergoing assisted reproductive treatmentEUCTR2010-019287-37-ESFinox AG372